NCT00421603View on ClinicalTrials.gov

A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Cocaine Dependence
Interventions
DRUG

Adderall-XR and Topiramate

Adderall-XR 60mg/day and Topiramate 300mg/day

DRUG

Placebo

Placebo

Trial Locations (1)

10032

STARS, New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00421603 - A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine Dependence | Biotech Hunter | Biotech Hunter